OTCMKTS:BRTXBioRestorative Therapies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioRestorative Therapies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0001 0.00 (0.00 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.91Volume1.60 million shsAverage Volume65.13 million shsMarket Capitalization$163,920.00P/E RatioN/ADividend YieldN/ABeta1 ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesSocial Media BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells for the treatment of disc/spine disease and metabolic disorders. The company's lead cell therapy candidate is the BRTX-100, which focuses on providing non-surgical treatment for protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. It also develops the ThermoStem program, a pre-clinical program for the treatment of metabolic diseases, such as type 2 diabetes, obesity, hypertension, and other metabolic disorders, as well as cardiac deficiencies. In addition, the company provides curved needle device, a needle system with a curved inner cannula that allows access to difficult-to-locate regions for the delivery or removal of fluids and other substances. Further, it offers skin care products under the Stem Pearls brand name. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is headquartered in Melville, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for BioRestorative Therapies. Previous Next 2.9 Community Rank Outperform VotesBioRestorative Therapies has received 94 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioRestorative Therapies has received 69 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioRestorative Therapies has received 57.67% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioRestorative Therapies and other stocks. Vote “Outperform” if you believe BRTX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BRTX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBioRestorative Therapies does not currently pay a dividend.Dividend GrowthBioRestorative Therapies does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioRestorative Therapies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 12.20% of the stock of BioRestorative Therapies is held by insiders. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of BioRestorative Therapies is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioRestorative Therapies is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.58 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BRTX Previous Symbol CUSIPN/A CIKN/A Webwww.biorestorative.com Phone631-760-8100Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$110,000.00 Price / Sales1.49 Cash FlowN/A Price / Cash FlowN/A Book Value($0.68) per share Price / Book0.00Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-12,520,000.00 Net Margins-13,124.41% Return on EquityN/A Return on Assets-1,000.12%Miscellaneous Employees8 Outstanding Shares1,639,200,000Market Cap$163,920.00 Next Earnings DateN/A OptionableNot Optionable OTC:BRTX Rates by TradingView Receive BRTX News and Ratings via Email Sign-up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. BioRestorative Therapies (OTCMKTS:BRTX) Frequently Asked Questions How has BioRestorative Therapies' stock been impacted by COVID-19 (Coronavirus)? BioRestorative Therapies' stock was trading at $0.0003 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BRTX shares have decreased by 66.7% and is now trading at $0.0001. View which stocks have been most impacted by Coronavirus. Has BioRestorative Therapies been receiving favorable news coverage? News stories about BRTX stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BioRestorative Therapies earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutBioRestorative Therapies. Who are some of BioRestorative Therapies' key competitors? Some companies that are related to BioRestorative Therapies include Fresenius Medical Care AG & Co. (FMS), Davita (DVA), Progyny (PGNY), Tivity Health (TVTY), HemaCare (HEMA), Catasys (CATS), American Renal Associates (ARA), Emmaus Life Sciences (EMMA), Baudax Bio (BXRX), Pacific Health Care Organization (PFHOD), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO) and American Caresource (GNOW). View all competitors. What other stocks do shareholders of BioRestorative Therapies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioRestorative Therapies investors own include Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX), Pharmacyte Biotech (PMCB), Sierra Oncology (SRRA), Ibio (IBIO), Actinium Pharmaceuticals (ATNM), Inpixon (INPX), SANUWAVE Health (SNWV), Kopin (KOPN) and Onconova Therapeutics (ONTX). Who are BioRestorative Therapies' key executives? BioRestorative Therapies' management team includes the following people: Mr. Mark R. Weinreb, Chairman, CEO & Pres (Age 66)Mr. Robert Paccasassi, VP of Quality & Compliance (Age 50)Ms. Mandy D. Clyde, VP of Operations & Sec. (Age 37)Dr. Wayne J. Olan, Clinical Director of Regenerative & Spine Program and Member of Scientific Advisory BoardMr. Lance Alstodt, Exec. VP & Chief Strategy Officer (Age 48) What is BioRestorative Therapies' stock symbol? BioRestorative Therapies trades on the OTCMKTS under the ticker symbol "BRTX." How do I buy shares of BioRestorative Therapies? Shares of BRTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is BioRestorative Therapies' stock price today? One share of BRTX stock can currently be purchased for approximately $0.00. How big of a company is BioRestorative Therapies? BioRestorative Therapies has a market capitalization of $163,920.00 and generates $110,000.00 in revenue each year. BioRestorative Therapies employs 8 workers across the globe. What is BioRestorative Therapies' official website? The official website for BioRestorative Therapies is www.biorestorative.com. How can I contact BioRestorative Therapies? BioRestorative Therapies' mailing address is 40 MARCUS DRIVE, MELVILLE NY, 11747. The company can be reached via phone at 631-760-8100 or via email at [email protected] This page was last updated on 5/29/2020 by MarketBeat.com Staff
